Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Hongtianli Pharmaceutical is a specialized pharmaceutical manufacturer based in the Daxing District of Beijing, China. Established in 1994, the company focuses on the production of both traditional Chinese medicines (TCM) and modern chemical pharmaceuticals, with a strong emphasis on respiratory and cardiovascular health. Its flagship products include Compound Liquorice Tablets and Houttuynia Cordata mixtures, which are widely distributed in the Chinese domestic market for treating coughs and respiratory infections. The company operates GMP-certified facilities capable of producing various dosage forms, including tablets, capsules, and oral liquids. Beijing Hongtianli Pharmaceutical maintains a reputation for quality in the production of essential medicines and continues to serve as a key player in the regional pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Hongtianli Pharmaceutical.